Gentex's Q3 2025 results reflect solid revenue growth driven by the VOXX acquisition, despite core revenue declines and regional production challenges.

• Consolidated net sales reached $655.2 million, an 8% increase year-over-year, aided by $84.9 million from VOXX.
• Core Gentex revenue fell 6% to $570.3 million, impacted by a 14% decline in European sales and a 35% drop in China.
• Gross margin improved to 34.4%, a 90 basis point reduction due to tariffs partially offset by operational efficiencies.
• Operating expenses surged to $102.8 million, primarily due to VOXX-related costs, with core expenses up modestly.
• Net income attributable to Gentex decreased to $101 million from $122.5 million last year, affected by a prior year's one-time gain.